The commercially sensible thing is for Oaktree to look at the risks to the loan capital and accrued interest. That will be their priority, which is likely not to be "aligned" with the priority of Mesoblast's financial officer. They could decide that no further extension is possible given the financial position and the lack of milestones being achieved.
Instead Mesoblast will have to realign their priorities unless SI can renegotiate the deal in the next 72 hours, but Oaktree would want something in return. It seems very unlikely that SI will want to personally guarantee the loan.
Crimes Against Humanity, page-46
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
0.000(0.00%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.08 | $5.380M | 4.893M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 69437 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 19999 | 1 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |